Last quarter (Q ), Microbot Medical's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Microbot Medical's net income was $-3.15M. See Microbot Medical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	$ -4.56M	$ -3.88M	-	-
Gross Profit	-	-	$ 4.56M	$ 3.88M	-	-
Operating Expense	$ 9.86M	$ 9.86M	$ 13.28M	$ 11.36M	$ 9.09M	$ 7.24M
Operating Income	$ -9.86M	$ -9.86M	$ -13.28M	$ -11.36M	$ -9.09M	$ -7.24M
Net Non Operating Interest Income Expense	$ 228.00K	$ 228.00K	$ 118.00K	$ 44.00K	$ -80.00K	$ -103.00K
Other Income Expense	$ 2.00K	$ 2.00K	$ 5.00K	-	-	$ 96.00K
Pretax Income	$ -10.74M	$ -10.74M	$ -13.17M	$ -11.31M	$ -9.17M	$ -7.25M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -10.74M	$ -10.74M	$ -13.17M	$ -11.31M	$ -9.17M	$ -7.25M
Basic EPS	$ -1.09	$ -1.05	$ -1.81	$ -1.59	$ -1.29	$ -1.70
Diluted EPS	$ -1.09	$ -1.05	$ -1.81	$ -1.59	$ -1.29	$ -1.70
Basic Average Shares	$ 40.80M	$ 10.20M	$ 7.26M	$ 7.11M	$ 7.12M	$ 4.27M
Diluted Average Shares	$ 40.80M	$ 10.20M	$ 7.26M	$ 7.11M	$ 7.12M	$ 4.27M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 9.86M	$ 9.86M	$ 8.72M	$ 7.48M	$ 9.09M	$ 7.24M
Net Income From Continuing And Discontinued Operation	$ -10.74M	$ -10.74M	$ -13.17M	$ -11.31M	$ -9.17M	$ -7.25M
Normalized Income	$ -5.12M	$ -7.37M	-	-	$ -9.17M	$ -7.34M
Interest Expense	-	-	-	-	$ 80.00K	$ 103.00K
EBIT	$ -10.74M	$ -10.74M	$ -13.17M	$ -11.31M	$ -9.09M	$ -7.14M
EBITDA	$ -10.63M	$ -10.63M	$ -13.07M	$ -11.24M	$ -9.02M	$ -7.06M

Currency in USD

Microbot Medical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing